Business Wire

AMAALA

4.11.2020 13:32:11 CET | Business Wire | Press release

Share
AMAALA and OceanoScientific Steer Environmental Research Sailing Expedition

AMAALA, the ultra-luxury destination located along Saudi Arabia’s north western coast, took to the seas with Monaco-based OceanoScientific on a two-week scientific expedition. The expedition was in line with AMAALA’s desire to measure and understand the impact of river water pollutants on human and sea life.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201104005308/en/

The expedition was undertaken with a two-fold objective to determine the nature and density of the chemical compounds that affect the marine environment. It also placed a wider focus on the impact of chemical contaminants on the ocean and human health, and validates the applicability of the expedition’s sampling method, using a cost-effective research alternative with a zero-carbon emission vessel.

Over the course of two weeks, the crew collected water samples from various points within a triangle of 1,500 nautical miles in the western Mediterranean.

These samples were handed over to the Institut Français de Recherche pour l'Exploitation de la Mer (Ifremer) by the crew and AMAALA Chief Executive Officer Nicholas Naples and Chief Sustainability Officer Brendan Jack at the last port of call in La Seyne-sur-Mer, France. The scientists at the Ifremer, who advised on the scientific aspects of the undertaking, will now quantify and analyse the concentration of metals and elements such as cadmium, lead, nickel and mercury, all of which can alter the composition of the sea and affect the marine food chain.

The expedition and the results unearthed as part of its study will inform AMAALA’s own conservation efforts. The Red Sea and the Mediterranean Sea are neighbouring seas and part of one global ocean system where changes in one, create ripples in the other. With its vibrant coral gardens and rich underwater life, the Red Sea coast at AMAALA has a thriving ecosystem that the destination aims to preserve and nurture. To this end, it has forged partnerships with global marine conservation entities, including the Prince Albert II of Monaco Foundation, the Centre Scientifique de Monaco, and the Oceanographic Institute.

Commenting on the expedition, AMAALA Chief Executive Officer Nicholas Naples, said “We are proud to sponsor the OceanoScientific Expedition – it perfectly aligns with our goal to create a luxury destination that is a global leader in sustainable tourism. Being part of expeditions and studies like this, arms us with the deeper insight and scientific knowledge required to preserve and protect our local ecosystem, especially the Red Sea coral reefs. This expedition also illustrates our vision of creating experiences that brings diverse interests and cultures together.”

Yvan Griboval, circumnavigator explorer and member of the Yacht Club de Monaco, who led the expedition said, “While almost everyone has realised that plastic pollution is an appalling scourge on the ocean, we want to show that chemical contaminants - metallic and organic - that pollute the sea and poison the phytoplankton and plankton at the start of the food chain, are found in our dinner plates at the other end of the chain of life.”

The expedition was conducted on the specially commissioned AMAALA Explorer, a former record-breaking 110-foot racing maxi-catamaran that was converted into a scientific research ship with zero carbon emissions. It functioned as the expedition’s lodging and lab.

HSH Prince Albert II of Monaco on 15 October 2020 was on hand to bid the crew farewell from the marina of the Yacht Club de Monaco. The AMAALA Explorer made port calls in Porto Cervo, Italy; Barcelona, Spain; and La Seyne-sur-Mer, France where water samples were handed over to scientists, before returning to Monaco.

The vessel and expedition were skippered by Yvan Griboval, who worked with a team of scientists specialised in the study of organic contaminants, including an onboard Swedish marine scientist Linn Sekund and AMAALA Director of Sports Marc Archer.

A short documentary film about the expedition, in English and French, will be distributed in 2021, along with scientific results in late 2021 and scientific publication in late 2023.

*Source: AETOSWire

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 14:29:00 CEST | Press release

Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release

Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release

New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye